19-01-2015, 01:30 AM
material about nanobots the artifical blood for delivering seminar.
|
nanobots the artificial blood pdf
|
material about nanobots the artifical blood for delivering seminar.
07-04-2017, 03:53 PM
Nanobots is a goo seminar theme for the diverse branch. In the future "vascular" (vascular-like machine) would replace human blood with about 500 billion nanorobots distributed through the vasculature of the body as a coating. This was said by Robert A. Freitas Jr. (author, "Nanomedicine"). It could eradicate heart disease, stroke, and other vascular problems; Eliminate parasites, bacteria, viruses and metastases from cancer cells to limit the spread of bloodborne diseases; Move lymphocytes more rapidly to improve immune response; Reduce susceptibility to chemical, biochemical and parasitic poisons; Improve physical endurance and endurance; And partially protect from various accidents and other physical damage.
Artificial blood is a product made to act as a substitute for red blood cells. While true blood serves many different functions, artificial blood is designed for the sole purpose of transporting oxygen and carbon dioxide throughout the body. Depending on the type of artificial blood, it can be produced in different ways using synthetic production, chemical isolation or recombinant biochemical technology. The development of the first blood substitutes goes back to the early 1600's, and the search for substitute ideal blood continues. Several manufacturers have products in clinical trials; However, no truly safe and effective artificial blood product is currently marketed. It is anticipated that when an artificial blood product is available, it will have annual sales of more than $ 7.6 billion in the United States alone.
Artificial blood is a product made to act as a substitute for red blood cells. While true blood serves many different functions, artificial blood is designed for the sole purpose of transporting oxygen and carbon dioxide throughout the body. Depending on the type of artificial blood, it can be produced in different ways using synthetic production, chemical isolation or recombinant biochemical technology. The development of the first blood substitutes goes back to the early 1600's, and the search for substitute ideal blood continues. Several manufacturers have products in clinical trials; However, no truly safe and effective artificial blood product is currently marketed. It is anticipated that when an artificial blood product is available, it will have annual sales of more than $ 7.6 billion in the United States alone.
|
« Next Oldest | Next Newest »
|
